![Potassium Channel Modulator Reduces Focal Onset Seizure Frequency in Clinical Trials - Practical Neurology Potassium Channel Modulator Reduces Focal Onset Seizure Frequency in Clinical Trials - Practical Neurology](https://core4.bmctoday.net/storage/images/220627_XEN1101_1656361529.jpg)
Potassium Channel Modulator Reduces Focal Onset Seizure Frequency in Clinical Trials - Practical Neurology
![Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study - The Lancet Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study - The Lancet](https://www.thelancet.com/cms/attachment/2070050435/2067854863/gr1.gif)
Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study - The Lancet
![Hippocampal magnetic resonance imaging in focal onset seizure with impaired awareness—descriptive study from tertiary care centre in southern part of India | The Egyptian Journal of Neurology, Psychiatry and Neurosurgery | Full Hippocampal magnetic resonance imaging in focal onset seizure with impaired awareness—descriptive study from tertiary care centre in southern part of India | The Egyptian Journal of Neurology, Psychiatry and Neurosurgery | Full](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs41983-021-00347-8/MediaObjects/41983_2021_347_Fig1_HTML.png)